Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek P Narendra

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Aging and Disease|December 16, 2025
Phosphorylated Ubiquitin as a Clinical Biomarker for Mitochondrial Damage in Neurodegenerative DiseasesFabienne C Fiesel, Jens O Watzlawik, Michael G Heckman, et al.
Brain : a Journal of Neurology|May 31, 2022
Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's diseaseWilliam Zhu, Xiaoping Huang, Esther Yoon, et al.
The Journal of Clinical Investigation|June 14, 2022
OMA1 mediates local and global stress responses against protein misfolding in CHCHD10 mitochondrial myopathyMario K Shammas, Xiaoping Huang, Beverly P Wu, et al.
Cells|September 27, 2024
Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275WBernardo A Bustillos, Liam T Cocker, Mathew A Coban, et al.
Acta Neuropathologica Communications|May 21, 2025
Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolismSandra Harjuhaahto, Manu Jokela, Jayasimman Rajendran, et al.
Brain : a Journal of Neurology|March 30, 2026
Clinical and biochemical characterization of amyotrophic lateral sclerosis in a CHCHD10 R15L familyJustin Y Kwan, Christian I Lantz, Vlad A Korobeynikov, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Clinical, neuropathological, and biochemical characterization of ALS in a large CHCHD10 R15L familyJustin Y Kwan, Christian I Lantz, Vlad A Korobeynikov, et al.
Brain : a Journal of Neurology|April 22, 2026
Machine learning model based on plasma proteomics for the identification of Parkinson's diseaseBoluwatife Adewale, Ruth Chia, Ruin Moaddel, et al.
Nature Medicine|August 19, 2025
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosisRuth Chia, Ruin Moaddel, Justin Y Kwan, et al.
Autophagy|September 12, 2012
Guidelines for the use and interpretation of assays for monitoring autophagyDaniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Aging and Disease|December 16, 2025
Phosphorylated Ubiquitin as a Clinical Biomarker for Mitochondrial Damage in Neurodegenerative DiseasesFabienne C Fiesel, Jens O Watzlawik, Michael G Heckman, et al.
Brain : a Journal of Neurology|May 31, 2022
Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's diseaseWilliam Zhu, Xiaoping Huang, Esther Yoon, et al.
The Journal of Clinical Investigation|June 14, 2022
OMA1 mediates local and global stress responses against protein misfolding in CHCHD10 mitochondrial myopathyMario K Shammas, Xiaoping Huang, Beverly P Wu, et al.
Cells|September 27, 2024
Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275WBernardo A Bustillos, Liam T Cocker, Mathew A Coban, et al.
Acta Neuropathologica Communications|May 21, 2025
Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolismSandra Harjuhaahto, Manu Jokela, Jayasimman Rajendran, et al.
Brain : a Journal of Neurology|March 30, 2026
Clinical and biochemical characterization of amyotrophic lateral sclerosis in a CHCHD10 R15L familyJustin Y Kwan, Christian I Lantz, Vlad A Korobeynikov, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Clinical, neuropathological, and biochemical characterization of ALS in a large CHCHD10 R15L familyJustin Y Kwan, Christian I Lantz, Vlad A Korobeynikov, et al.
Brain : a Journal of Neurology|April 22, 2026
Machine learning model based on plasma proteomics for the identification of Parkinson's diseaseBoluwatife Adewale, Ruth Chia, Ruin Moaddel, et al.
Nature Medicine|August 19, 2025
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosisRuth Chia, Ruin Moaddel, Justin Y Kwan, et al.
Autophagy|September 12, 2012
Guidelines for the use and interpretation of assays for monitoring autophagyDaniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, et al.
Pageof 6